e-learning
resources
ERJ
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward
Lederer David J.
Source:
Eur Respir J 2013; 42: 1446-1448
Journal Issue:
December
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lederer David J.. Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward. Eur Respir J 2013; 42: 1446-1448
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay.
The cryoTBB role in the diagnostic work-up of IPF: an European perspective; emergent standardization guidelines
Acute exacerbations of IPF: A neglected threat in IPF ?
Related content which might interest you:
Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences
Source: Eur Respir Rev 2015; 24: 420-427
Year: 2015
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Source: Eur Respir J 2015; 46: 243-249
Year: 2015
Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Idiopathic pulmonary fibrosis trials: recommendations for the jury
Source: Eur Respir J 2011; 38: 1002-1004
Year: 2011
Challenges in idiopathic pulmonary fibrosis trials: the point on end-points
Source: Eur Respir Rev 2011; 20: 195-200
Year: 2011
Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017
Year: 2017
Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Historical eye on idiopathic pulmonary fibrosis: redefining the mortality scenario.
Source: Virtual Congress 2020 – New clinical insights into idiopathic pulmonary fibrosis
Year: 2020
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015
A global registry for idiopathic pulmonary fibrosis: the time is now
Source: Eur Respir J 2014; 44: 273-276
Year: 2014
Combination therapy in idiopathic pulmonary fibrosis: the way ahead will be hard
Source: Eur Respir J 2015; 45: 1208-1210
Year: 2015
Idiopathic pulmonary fibrosis: present understanding and future options
Source: Eur Respir Rev 2011; 20: 132-133
Year: 2011
Clinical course of idiopathic pulmonary fibrosis (IPF): Prediction and outcome
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Clinical trials in idiopathic pulmonary fibrosis: a word of caution concerning choice of outcome measures
Source: Eur Respir J 2005; 26: 755-758
Year: 2005
Where do we go from here? Clinical drug development in idiopathic pulmonary fibrosis
Source: Eur Respir J 2015; 45: 1218-1220
Year: 2015
Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour
Source: Eur Respir J 2007; 30: Suppl. 51, 488s
Year: 2007
Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm
Source: Eur Respir J 2015; 46: 512-520
Year: 2015
Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches
Source: Eur Respir J 2006; 28: 463-465
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept